Skip to Main Content
Contribute Try STAT+ Today

Digital behavioral health programs are making a bold pitch to payers, employers, and patients themselves: Shell out upfront for our virtual coaching and remote monitoring, and we’ll save you money by avoiding costly complications from diabetes and other diseases in the long run.

For diabetes, which nearly tops the list of chronic health conditions by cost, many virtual programs are promoting continuous glucose monitoring as part of that promise. “We just started to see that with CGMs, it’s a foregone conclusion that they’re going to be the dominant solution,” said Sean Duffy, co-founder and CEO of digital care company Omada Health. The devices, which stream users’ blood glucose data throughout the day, are most commonly used by people who need multiple daily doses of insulin to manage their diabetes, but “this isn’t just for people who inject insulin,” said Duffy. “We decided that it was going to be table stakes and Omada needed to power CGM and coaching in a really deep way.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment